Vanguard Group Inc Pmv Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,153,600 shares of PMVP stock, worth $3.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,153,600

Previous 2,175,061 0.99%

Holding current value

$3.06 Million

Previous $2.37 Million 3.71%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$0.84 - $1.19 $18,027 - $25,538	-21,461 Reduced 0.99%	2,153,600 $2.28 Million
Q1 2025 May 09, 2025	BUY	$1.09 - $1.57 $34,835 - $50,175	31,959 Added 1.49%	2,175,061 $2.37 Million
Q4 2024 Feb 11, 2025	SELL	$1.47 - $1.78 $202,420 - $245,107	-137,701 Reduced 6.04%	2,143,102 $3.24 Million
Q3 2024 Nov 13, 2024	SELL	$1.44 - $1.69 $1,853 - $2,175	-1,287 Reduced 0.06%	2,280,803 $3.4 Million
Q2 2024 Aug 13, 2024	SELL	$1.51 - $2.21 $256,731 - $375,746	-170,021 Reduced 6.93%	2,282,090 $3.7 Million
Q1 2024 May 10, 2024	BUY	$1.51 - $3.12 $70,674 - $146,028	46,804 Added 1.95%	2,452,111 $4.17 Million
Q4 2023 Feb 14, 2024	BUY	$1.23 - $6.6 $446,472 - $2.4 Million	362,986 Added 17.77%	2,405,307 $7.46 Million
Q3 2023 Nov 14, 2023	BUY	$6.01 - $8.93 $43,800 - $65,081	7,288 Added 0.36%	2,042,321 $12.5 Million
Q2 2023 Aug 14, 2023	BUY	$3.94 - $6.27 $282,155 - $449,013	71,613 Added 3.65%	2,035,033 $12.7 Million
Q1 2023 May 15, 2023	SELL	$4.77 - $9.16 $3.77 Million - $7.24 Million	-790,186 Reduced 28.7%	1,963,420 $9.37 Million
Q4 2022 Feb 10, 2023	SELL	$8.17 - $12.95 $5.56 Million - $8.81 Million	-680,359 Reduced 19.81%	2,753,606 $24 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $889,211 - $1.34 Million	78,001 Added 2.32%	3,433,965 $40.9 Million
Q2 2022 Aug 12, 2022	BUY	$9.23 - $22.43 $5.7 Million - $13.8 Million	617,081 Added 22.53%	3,355,964 $47.8 Million
Q1 2022 May 13, 2022	BUY	$14.86 - $23.55 $1.35 Million - $2.14 Million	90,937 Added 3.43%	2,738,883 $57 Million
Q4 2021 Feb 14, 2022	SELL	$19.99 - $30.24 $108,905 - $164,747	-5,448 Reduced 0.21%	2,647,946 $61.2 Million
Q3 2021 Nov 12, 2021	BUY	$26.84 - $36.58 $11 Million - $15.1 Million	411,683 Added 18.36%	2,653,394 $79.1 Million
Q2 2021 Aug 13, 2021	BUY	$28.01 - $36.01 $62.8 Million - $80.7 Million	2,241,711 New	2,241,711 $76.6 Million

Others Institutions Holding PMVP

# of Institutions

Shares Held

37.6M

Call Options Held

100

Put Options Held

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $64.8M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Pmv Pharmaceuticals, Inc. Transaction History